LifeStance Health Group, Inc.
LFST
$5.49
$0.091.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.86% | 16.31% | 18.50% | 20.08% | 20.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.86% | 16.31% | 18.50% | 20.08% | 20.56% |
| Cost of Revenue | 10.47% | 11.56% | 12.61% | 14.78% | 15.96% |
| Gross Profit | 21.60% | 27.58% | 33.20% | 33.68% | 32.57% |
| SG&A Expenses | 5.63% | 4.54% | 3.84% | 0.26% | 0.61% |
| Depreciation & Amortization | -30.67% | -25.96% | -11.79% | 1.80% | 10.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.34% | 6.92% | 8.37% | 9.48% | 10.78% |
| Operating Income | 100.74% | 88.90% | 76.50% | 63.12% | 48.59% |
| Income Before Tax | 86.43% | 79.71% | 72.11% | 60.78% | 14.27% |
| Income Tax Expenses | 36.73% | 82.97% | 99.16% | 124.21% | 60.34% |
| Earnings from Continuing Operations | 89.30% | 79.41% | 69.16% | 49.30% | 8.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.30% | 79.41% | 69.16% | 49.30% | 8.11% |
| EBIT | 100.74% | 88.90% | 76.50% | 63.12% | 48.59% |
| EBITDA | 3,103.58% | 307.63% | 190.62% | 135.20% | 102.20% |
| EPS Basic | 89.53% | 79.98% | 70.11% | 50.55% | 11.41% |
| Normalized Basic EPS | 80.71% | 73.20% | 62.99% | 55.65% | 43.70% |
| EPS Diluted | 89.58% | 80.14% | 69.34% | 49.80% | 10.56% |
| Normalized Diluted EPS | 80.71% | 73.20% | 62.99% | 55.65% | 43.70% |
| Average Basic Shares Outstanding | 2.35% | 2.98% | 3.59% | 3.56% | 4.09% |
| Average Diluted Shares Outstanding | 2.84% | 3.48% | 3.59% | 3.56% | 4.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |